8C71.3

ICD-11 MMS 2026-01

Drug-induced myotonia

Description

Drug-induced myotonia refers to the myotonia-inducing effects of certain drugs. Hypocholesterolaemic agents may induce myotonia by altering the sterol composition of the muscle cell membrane, while other drugs including beta-adrenergic blockers and agonists, succinylcholine and diuretics may exacerbate or unmask pre-existing myotonia.

Index terms

  • Drug-induced myotonia
  • drug myotonia
  • medicament-induced myotonia

Excludes

  • http://id.who.int/icd/entity/1159616108 – Secondary myopathies
  • http://id.who.int/icd/entity/1425591047 – Myasthenia gravis or certain specified neuromuscular junction disorders

Exclusions from above levels

  • http://id.who.int/icd/entity/155258022 – Metabolic disorders
  • LD26.41 – Arthrogryposis multiplex congenita
  • 05 – Endocrine, nutritional or metabolic diseases
Show allHide
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 19 – Certain conditions originating in the perinatal period
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • 8C71.0 – Myotonic dystrophy
  • 8C71.1 – Chondrodystrophic myotonia
  • 8C71.2 – Myotonia congenita
  • 8C71.4 – Neuromyotonia
  • 8C71.5 – Pseudomyotonia
  • 8C71.Y – Other specified myotonic disorders
  • 8C71.Z – Myotonic disorders, unspecified

Foundation entity

Drug-induced myotonia – http://id.who.int/icd/entity/40657776

Allowed postcoordination axes

Part of: 8C71: Myotonic disorders › 08: Diseases of the nervous system